AZT.OL Live signaler | Maksimer profitt med Getagraph.com

KJøP 2803 min ago

@ NOK25.80

Utstedt: 26 apr 2024 @ 14:41

Avkastning: 0.78%

Forrige signal: apr 26 - 14:23

Forrige signal: Selg

Avkastning: -0.39 %

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 16:25):
Our systems believe the stock currently is overvalued by 0.01% compare to its pairs and should correct downwards.

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing...

Stats
Dagens volum	23 429.00
Gjennomsnittsvolum	38 638.00
Markedsverdi	1.32B
EPS	NOK0 ( 2024-01-31 )
Neste inntjeningsdato	( NOK0.0700 ) 2024-05-07
Last Dividend	NOK0 ( N/A )
Next Dividend	NOK0 ( N/A )
P/E	76.47
ATR14	NOK1.250 (4.84%)

Korrelasjon (AI algo v.1.1b): Overvalued: -0.01% NOK25.80 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: -0.99 (very strong negative)

Kort: 0.00 (neutral)

Signal:(0) Neutral

Arcticzymes Technologies Korrelasjon

10 Mest positive korrelasjoner
EQNR.OL	0.878
OTS.OL	0.855
CADLR.OL	0.847
XXL.OL	0.846
BEWI.OL	0.841
TOM.OL	0.839
MULTI.OL	0.819
VAR.OL	0.819
B2H.OL	0.818
NAVA.OL	0.815

10 Mest negative korrelasjoner
ZAL.OL	-0.882
SIOFF.OL	-0.876
FROY.OL	-0.86
SOAG.OL	-0.859
PROT.OL	-0.852
VEI.OL	-0.85
ODL.OL	-0.837
SALM.OL	-0.833
SVEG.OL	-0.83
PGS.OL	-0.83

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Arcticzymes Technologies Korrelasjon - Valuta/Råvare

0.88
( strong )

0.91
( very strong )

0.00
( neutral )

0.78
( moderate )

0.00
( neutral )

-0.94
( very strong negative )

Arcticzymes Technologies Økonomi

Annual	2023
Omsetning:	NOK118.94M
Bruttogevinst:	NOK47.77M (40.16 %)
EPS:	NOK0.370

FY	2023
Omsetning:	NOK118.94M
Bruttogevinst:	NOK47.77M (40.16 %)
EPS:	NOK0.370

FY	2022
Omsetning:	NOK136.97M
Bruttogevinst:	NOK131.79M (96.22 %)
EPS:	NOK0.650

FY	2021
Omsetning:	NOK127.97M
Bruttogevinst:	NOK124.09M (96.96 %)
EPS:	NOK0.940

Financial Reports:

No articles found.

Arcticzymes Technologies

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase and derived kits for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining DNA /RNA fragments. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was incorporated in 1990 and is headquartered in Tromsø, Norway.